According to our results, BCL2 expression was higher at Dx compared to PI and CR and was high again at RL; therefore, it seems to be a dynamic marker that reflects the evolution of AML and could be informative of impending RL. The gene discussed is BCL2; the disease is acute myeloid leukemia.